Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Refractory Differentiated Thyroid Gland Carcinoma × dabrafenib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 7 Neoplasms 3 Skin Neoplasms 1 Sarcoma 1 Refractory Differentiated Thyroid Gland Carcinoma 1 Neoplasm Metastasis 1 Fever 1 Differentiated Thyroid Cancer (DTC) 1 Ameloblastoma 1

Interventions

trametinib 1 dabrafenib 1 cabozantinib 1 Specimen Handling 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06475989 2026-03-02

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

Eastern Cooperative Oncology Group

Phase 3 Recruiting

Refractory Differentiated Thyroid Gland Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡